DNA Link Inc <127120.KQ> :Says it signed a 2.15 billion won contract with Hokkaido System Science Co.,Ltd to provide genome analysis service in Japan.
DNA Link Inc <127120.KQ> :Says it signed a 2.45 billion won contract with Korea Centers for Disease Control and Prevention to build 2017 Korean genome information system.
MDxHealth SA :MDxHealth awarded US department of Veterans Affairs (VA) contract for ConfirmMDx testing.
Bachem Holding AG : Renews supply contract with AstraZeneca for the peptide active substance Goserelin .Under the terms of the agreement, AstraZeneca will continue acquiring the peptide active substance Goserelin from Bachem for the next five years.
Doxa AB : Signs deal in Asia .Has signed second distribution agreement with Galla Dental, this time for sale in Singapore through its sister company SA Dental Supply.
PCI Biotech Holding ASA : PCI Biotech awarded 13.8 million Norwegian crowns ($1.7 million) from Research Council of Norway to further development of PCI for use in vaccination .Project will be initiated in Q3 2017 and run for three and a half years.
Celltrion Inc <068270.KQ> :Says it signed a 53.25 billion won contract with Celltrion Healthcare co.,Ltd, to sell antibody drug.
Celltrion Inc <068270.KQ> : Says it signs 149.10 billion won contract with Celltrion Healthcare to sell remsima .Says the contract period from Dec. 21 to Dec. 31.
Xbrane Biopharma AB : Signs agreement with BioAvenir for sales and marketing of Spherotide in Israel . Has signed distribution agreement with BioAvenir for sales and marketing of Spherotide on Israeli market . Estimates, based on expected price and penetration, that Spherotide has sales potential of about 5 million Swedish crowns ($535,361) annually in Israel .Xbrane and BioAvenir will share profits from sales of Spheritode in Israel and Xbrane will receive license fee of 1 million crowns divided in upfront and milestone payments.